Skip to main navigation Skip to search Skip to main content

Randomized trial comparing dose reduction and growth factor supplementation for management of hematological side effects in HIV/hepatitis C virus patients receiving pegylated-interferon and ribavirin

  • Andrew H. Talal
  • , Ruei Chi Liu
  • , Marija Zeremski
  • , Rositsa Dimova
  • , Lorna Dove
  • , Daniel Pearce
  • , Tarek Hassanein
  • , Leleka Doonquah
  • , David Aboulafia
  • , Jorge Rodriguez
  • , Hector Bonilla
  • , Jeffrey Galpin
  • , Judy A. Aberg
  • , Barbara Johnston
  • , Marshall J. Glesby
  • , Ira M. Jacobson

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized trial comparing dose reduction and growth factor supplementation for management of hematological side effects in HIV/hepatitis C virus patients receiving pegylated-interferon and ribavirin'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science